Grimwood R E, Ferris C F, Nielsen L D, Huff J C, Clark R A
J Invest Dermatol. 1986 Jul;87(1):42-6. doi: 10.1111/1523-1747.ep12523552.
Epidermal cells in vitro produce and deposit fibronectin (FN) in the pericellular matrix. Such FN production by epidermal cells may be involved in vivo in wound reepithelialization, tissue morphogenesis, and growth of epithelial tumors. The purpose of this study was to examine whether the FN, previously shown to be within and surrounding human basal cell carcinoma (BCC) lobules, was in part the product of epidermal-derived tumor cells. To examine this question we took advantage of our ability to grow human BCC in nude mice. Since we could demonstrate that all stromal cells surrounding the BCC were of mouse origin, antibodies specific for human FN would distinguish epithelial-derived FN from mesenchymal-derived FN. Five solid BCCs were implanted subcutaneously in nude mice. Growing tumors were removed after 60 days, snap-frozen, sectioned on a cryostat, and verified microscopically as BCC. The Hoescht DNA stain, which can distinguish mouse and human nuclei, demonstrated that mouse, not human, fibroblasts occupied the stroma surrounding each tumor lobule. Sections of all 5 BCCs were stained by immunofluorescence and immunoperoxidase techniques with antibodies to bullous pemphigoid (BP) antigen, laminin (LM), and FN. BP antigen and LM were present at the basement membrane zone (BMZ) of all tumor lobules as previously described for in situ BCC. FN staining was present along the BMZ, within the tumor lobules, and in the surrounding stroma. Antibodies to human FN were passed over a mouse FN affinity column to absorb antibodies which cross-reacted with mouse FN. The resultant antibody preparation, which was specific for human FN in this system, continued to demonstrate FN along the BMZ and within the tumors, but failed to stain FN in more distant stroma. Epidermal-derived cells, therefore, can synthesize and deposit FN in vivo in adjacent extracellular matrix. We speculate that this FN matrix may facilitate growth of BCC in this model.
体外培养的表皮细胞在细胞周围基质中产生并沉积纤连蛋白(FN)。表皮细胞产生的这种FN可能在体内参与伤口再上皮化、组织形态发生以及上皮肿瘤的生长。本研究的目的是检验先前显示存在于人类基底细胞癌(BCC)小叶内及周围的FN是否部分是表皮来源的肿瘤细胞的产物。为了研究这个问题,我们利用了在裸鼠体内培养人类BCC的能力。由于我们能够证明BCC周围的所有基质细胞均来自小鼠,因此针对人类FN的特异性抗体将能够区分上皮来源的FN和间充质来源的FN。将5个实体BCC皮下植入裸鼠体内。60天后取出生长的肿瘤,速冻,在低温恒温器上切片,并通过显微镜验证为BCC。能区分小鼠和人类细胞核的Hoescht DNA染色显示,占据每个肿瘤小叶周围基质的是小鼠成纤维细胞,而非人类成纤维细胞。使用针对大疱性类天疱疮(BP)抗原、层粘连蛋白(LM)和FN的抗体,通过免疫荧光和免疫过氧化物酶技术对所有5个BCC的切片进行染色。如先前原位BCC所述,所有肿瘤小叶的基底膜区(BMZ)均存在BP抗原和LM。FN染色出现在BMZ沿线、肿瘤小叶内以及周围基质中。将针对人类FN的抗体通过小鼠FN亲和柱,以吸收与小鼠FN发生交叉反应的抗体。在该系统中,所得的对人类FN具有特异性的抗体制剂,在BMZ沿线和肿瘤内仍能显示FN,但在更远的基质中无法对FN进行染色。因此,表皮来源的细胞能够在体内相邻的细胞外基质中合成并沉积FN。我们推测,在这个模型中,这种FN基质可能促进BCC的生长。